|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T81.49XA |
Infection following a procedure, other surgical site, initial encounter
|
T8149XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.69%
|
20.49%
|
8.31%
|
3.75%
|
2.51%
|
1.55%
|
1.01%
|
0.92%
|
0.59%
|
0.39%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T81.49XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
5,983
|
6,003
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
5,325
|
5,363
|
|
80053
|
COMPREHEN METABOLIC PANEL |
4,189
|
4,191
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,861
|
3,868
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,730
|
3,796
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
3,538
|
3,739
|
|
86140
|
C-REACTIVE PROTEIN |
3,188
|
3,190
|
|
87205
|
SMEAR GRAM STAIN |
2,961
|
3,181
|
|
J0878
|
DAPTOMYCIN INJECTION |
2,544
|
1,194,756
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
2,471
|
3,069
|
|
80048
|
METABOLIC PANEL TOTAL CA |
2,374
|
2,380
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
2,298
|
3,065
|
|
J3370
|
VANCOMYCIN HCL INJECTION |
2,165
|
6,601
|
|
87040
|
BLOOD CULTURE FOR BACTERIA |
2,100
|
2,550
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,942
|
4,599
|
|
85652
|
RBC SED RATE AUTOMATED |
1,911
|
1,911
|
|
J0696
|
CEFTRIAXONE SODIUM INJECTION |
1,651
|
11,291
|
|
83605
|
ASSAY OF LACTIC ACID |
1,364
|
1,413
|
|
87075
|
CULTR BACTERIA EXCEPT BLOOD |
1,334
|
1,465
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
1,293
|
1,698
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T81.49XA related to the following DRG Codes:
791
793
856-858
862-863
|
